A delegation of the LUMC visited the University of Edinburgh (UoE) from 9 till 11 November for multiple purposes, but for one thing in particular: to strengthen bonds. With just over a handful of colleagues, the LUMC traveled to Edinburgh to discuss current projects and future collaborations!
The week centered around the Eurolife network meetings, which were this time organized by the UoE. Colleagues from the Eurolife network, consisting of UoE, Semmelweis University, the University of Strasbourg, Karolinska Institutet, University Medical Center Gottingen, Medical University Innsbruck, Trinity College Dublin, the University of Barcelona, and the LUMC, discussed the collaboration strategy, current projects and other topics in the Education Alliance, Research and Steering Committee meetings. A multiplier event hosted by the network elaborated on the current two-year DATAETHICS project in which LUMC will host a winter school for students in Life Sciences & Health coming January for which you can sign up here! You can also read more about the DATAETHICS and the projects there.
UoE and LUMC have had successful collaborations throughout many years, for instance in student exchange and research projects. For the latter, the institutions for instance work on the One Health joint PhD programme, in which as many as eight different PhD projects have been introduced, supervised by both professors from UoE and LUMC and with students from both institutions. Students from the LUMC currently doing a semester in Edinburgh presented their experiences with great enthusiasm are excited to have been given the opportunity to study abroad during their studies.
These are just some snippets of the projects the two partners work on. The meetings proved fruitful to explore even more possibilities for collaboration and to assess how we can improve current activities. We thank the colleagues of UoE for the warm welcome and the lovely stay in Scotland!
The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.
The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11. Developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre (LUMC), it is the fourth vaccine to be administered in the European Union. The Netherlands has ordered more than 11 million vaccine doses.
“This is an achievement in alignment with the mission of VODAN-Africa to generate continuous, real-time, high velocity clinical observational patient data from resource-limited communities that have not been well represented in digital health data. The key feature is that the data produced remains in the health facility only. It will not leave the health facility. Since the data is machine-actionable the input of the data only happens once; in the deployable architecture, the data is used for four parallel use cases” (VODAN to Africa, 2022).